Moderna Downgraded To Neutral From Overweight At Piper Sandler
August 06, 2021 at 08:46 AM EDT
Piper Sandler analyst Edward Tenthoff downgraded Moderna to Neutral from Overweight with a price target of $445, up from $246, post the Q2 results.
